drugset / Trial / NCT01886690

A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery

NCT01886690

Phase 3 Completed 148 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.

Timeline

Start
2013-08-20
Primary completion
2014-08-18
Completion
2014-08-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carboxymethylcellulose Other / unclassified Other

Indications

No indication recorded.